Berndt Modig (Pharvaris B.V.)

Modig, Berndt (Pharvaris CEO before Prosensa 201003 CFO before Jerini 200310– CFO before Surplex AG)

	Organisation	Pharvaris B.V.
	Today	Pharvaris N.V. (Nasdaq: PHVS)
	Former/major organisation	Prosensa Holding B.V.
	Today	Prosensa Holding N.V.
	Group	BioMarin (Group)

Record changed: 2020-11-21

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Berndt Modig

[1] Pharvaris B.V.. (11/18/20). "Press Release: Pharvaris Announces $80 Million Series C Financing to Advance Novel Oral Bradykinin-B2-Receptor Antagonists for the Treatment of HAE". Zug....
[2] Pharvaris B.V.. (9/10/19). "Press Release: Pharvaris Announces $66 Million Series B Financing to Advance the Clinical Development of an Oral Therapy for Hereditary Angioedema". Leiden....
[3] Centogene AG. (5/4/18). "Press Release: Centogene Appoints Berndt Modig as New Supervisory Board Member". Rostock....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]